137 related articles for article (PubMed ID: 38130096)
1. Long-term use of everolimus for refractory arrhythmia in a child with tuberous sclerosis complex.
Hofmann C; Syrbe S; Hebe J; Kreft J; Stark S; Milde T; Völkers M; Hoffmann GF; Gorenflo M; Kovacevic A
Am J Med Genet A; 2024 May; 194(5):e63508. PubMed ID: 38130096
[TBL] [Abstract][Full Text] [Related]
2. Everolimus for severe arrhythmias in tuberous sclerosis complex related cardiac rhabdomyomas.
Silva-Sánchez MP; Alvarado-Socarras JL; Castro-Monsalve J; Meneses KM; Santiago J; Prada CE
Am J Med Genet A; 2021 May; 185(5):1525-1531. PubMed ID: 33590972
[TBL] [Abstract][Full Text] [Related]
3. Everolimus for cardiac rhabdomyomas in children with tuberous sclerosis. The ORACLE study protocol (everOlimus for caRdiac rhAbdomyomas in tuberous sCLErosis): a randomised, multicentre, placebo-controlled, double-blind phase II trial.
Stelmaszewski EV; Parente DB; Farina A; Stein A; Gutierrez A; Raquelo-Menegassio AF; Manterola C; de Sousa CF; Victor C; Maki D; Morón EM; de Abrantes FF; Iqbal F; Camacho-Vilchez J; Jimenez-Pavón J; Polania JP; Thompson L; Bonanato L; Diebold M; Da Silva MVCP; Nashwan MWJ; Galvani MAG; Idris OEA; Danos P; Ortiz-Lopez R; Mahmoud RAA; Gresse S; Loss KL
Cardiol Young; 2020 Mar; 30(3):337-345. PubMed ID: 31983379
[TBL] [Abstract][Full Text] [Related]
4. Everolimus treatment of a newborn with rhabdomyoma causing severe arrhythmia.
Öztunç F; Atik SU; Güneş AO
Cardiol Young; 2015 Oct; 25(7):1411-4. PubMed ID: 26339757
[TBL] [Abstract][Full Text] [Related]
5. Regression of symptomatic multiple cardiac rhabdomyomas associated with tuberous sclerosis complex in a newborn receiving everolimus.
Doğan V; Yeşil Ş; Kayalı Ş; Beken S; Özgür S; Ertuğrul İ; Bozkurt C; Örün UA; Karademir S
J Trop Pediatr; 2015 Feb; 61(1):74-7. PubMed ID: 25344617
[TBL] [Abstract][Full Text] [Related]
6. Everolimus for the Treatment of Tuberous Sclerosis Complex-Related Cardiac Rhabdomyomas in Pediatric Patients.
Dahdah N
J Pediatr; 2017 Nov; 190():21-26.e7. PubMed ID: 28888564
[No Abstract] [Full Text] [Related]
7. Cardiac rhabdomyomas: clinical progression, efficacy and safety of everolimus treatment.
Yıldırım S; Aypar E; Aydın B; Akyüz C; Aykan HH; Ertuğrul İ; Karagöz T; Alehan D
Turk J Pediatr; 2023; 65(3):479-488. PubMed ID: 37395967
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of mTOR inhibitor treatment in patients with tuberous sclerosis complex under 2 years of age - a multicenter retrospective study.
Saffari A; Brösse I; Wiemer-Kruel A; Wilken B; Kreuzaler P; Hahn A; Bernhard MK; van Tilburg CM; Hoffmann GF; Gorenflo M; Hethey S; Kaiser O; Kölker S; Wagner R; Witt O; Merkenschlager A; Möckel A; Roser T; Schlump JU; Serfling A; Spiegler J; Milde T; Ziegler A; Syrbe S
Orphanet J Rare Dis; 2019 May; 14(1):96. PubMed ID: 31053163
[TBL] [Abstract][Full Text] [Related]
9. Use of mTOR inhibitor everolimus in three neonates for treatment of tumors associated with tuberous sclerosis complex.
Goyer I; Dahdah N; Major P
Pediatr Neurol; 2015 Apr; 52(4):450-3. PubMed ID: 25682485
[TBL] [Abstract][Full Text] [Related]
10. Rapid resolution of cardiac rhabdomyomas following everolimus therapy.
Choudhry S; Nguyen HH; Anwar S
BMJ Case Rep; 2015 Dec; 2015():. PubMed ID: 26661560
[TBL] [Abstract][Full Text] [Related]
11. Everolimus treatment in a 3-month-old infant with tuberous sclerosis complex cardiac rhabdomyoma, severe left ventricular outflow tract obstruction, and hearing loss.
Çetin M; Aydın AA; Karaman K
Cardiol Young; 2021 Aug; 31(8):1359-1362. PubMed ID: 33658088
[TBL] [Abstract][Full Text] [Related]
12. Fetal Tuberous Sclerosis: Sirolimus for the Treatment of Fetal rhabdomyoma.
Dagge A; Silva LA; Jorge S; Nogueira E; Rebelo M; Pinto L
Fetal Pediatr Pathol; 2022 Oct; 41(5):800-806. PubMed ID: 34281475
[TBL] [Abstract][Full Text] [Related]
13. Treatment of Cardiac Rhabdomyomas with mTOR Inhibitors in Children with Tuberous Sclerosis Complex-A Systematic Review.
Sugalska M; Tomik A; Jóźwiak S; Werner B
Int J Environ Res Public Health; 2021 May; 18(9):. PubMed ID: 34062963
[TBL] [Abstract][Full Text] [Related]
14. Cardiac Rhabdomyomas in Tuberous Sclerosis Complex.
Castro-Monsalve J; Alvarado-Socarras JL; Mantilla KA; Forero L; Moreno A; Prada CE
J Pediatr; 2018 Jan; 192():264-264.e1. PubMed ID: 29128117
[No Abstract] [Full Text] [Related]
15. Accelerated Cardiac Rhabdomyoma Regression with Everolimus in Infants with Tuberous Sclerosis Complex.
Aw F; Goyer I; Raboisson MJ; Boutin C; Major P; Dahdah N
Pediatr Cardiol; 2017 Feb; 38(2):394-400. PubMed ID: 27878332
[TBL] [Abstract][Full Text] [Related]
16. Rapid Involution of Large Cardiac Rhabdomyomas With Everolimus Therapy.
Garg A; Gorla SR; Kardon RE; Swaminathan S
World J Pediatr Congenit Heart Surg; 2021 May; 12(3):426-429. PubMed ID: 31072227
[TBL] [Abstract][Full Text] [Related]
17. Prenatal diagnosis of giant cardiac rhabdomyoma in tuberous sclerosis complex: a new therapeutic option with everolimus.
Mlczoch E; Hanslik A; Luckner D; Kitzmüller E; Prayer D; Michel-Behnke I
Ultrasound Obstet Gynecol; 2015 May; 45(5):618-21. PubMed ID: 24913039
[TBL] [Abstract][Full Text] [Related]
18. Everolimus as a possible prenatal treatment of in utero diagnosed subependymal lesions in tuberous sclerosis complex: a case report.
Cavalheiro S; da Costa MDS; Richtmann R
Childs Nerv Syst; 2021 Dec; 37(12):3897-3899. PubMed ID: 34008055
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment with everolimus for severe heart failure with large cardiac rhabdomyomas.
Inoue S; Inuzuka R; Kakiuchi S; Sato A; Matsui H
Pediatr Int; 2022 Jan; 64(1):e15219. PubMed ID: 35912461
[No Abstract] [Full Text] [Related]
20. Rhabdomyomas and tuberous sclerosis complex: our experience in 33 cases.
Sciacca P; Giacchi V; Mattia C; Greco F; Smilari P; Betta P; Distefano G
BMC Cardiovasc Disord; 2014 May; 14():66. PubMed ID: 24884933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
